India Competent Cells Market Size & Outlook, 2025-2033
Related Markets
India competent cells market highlights
- The India competent cells market generated a revenue of USD 77.5 million in 2024 and is expected to reach USD 201.0 million by 2033.
- The India market is expected to grow at a CAGR of 11.2% from 2025 to 2033.
- In terms of segment, chemically competent cells was the largest revenue generating type in 2024.
- Electrocompetent Cells is the most lucrative type segment registering the fastest growth during the forecast period.
Competent cells market data book summary
| Market revenue in 2024 | USD 77.5 million |
| Market revenue in 2033 | USD 201.0 million |
| Growth rate | 11.2% (CAGR from 2025 to 2033) |
| Largest segment | Chemically competent cells |
| Fastest growing segment | Electrocompetent Cells |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemically Competent Cells, Electrocompetent Cells, Ultracompetent Cells |
Other key industry trends
- In terms of revenue, India accounted for 3.4% of the global competent cells market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China competent cells market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 377.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Competent Cells Market Scope
Competent Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Applied Science | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche-applied-science.com |
| Promega Corporation | View profile | - | - | - |
| Takara Bio Inc. | View profile | - | - | - |
| Agilent Technologies, Inc. | View profile | - | - | - |
| QIAGEN | View profile | - | - | - |
| Merck KGaA | View profile | - | - | - |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
India competent cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to competent cells market will help companies and investors design strategic landscapes.
Chemically competent cells was the largest segment with a revenue share of 43.48% in 2024. Horizon Databook has segmented the India competent cells market based on chemically competent cells, electrocompetent cells, ultracompetent cells covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to India competent cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India competent cells market databook
-
Our clientele includes a mix of competent cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India competent cells market , including forecasts for subscribers. This country databook contains high-level insights into India competent cells market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
India competent cells market size, by type, 2021-2033 (US$M)
India Competent Cells Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
